The global cell culture market size was estimated at USD 16.59 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 11.32% from 2023 to 2030. Its growth can be attributed to the rapid adoption of cell culture techniques to develop substrates for the safe production of viral vaccines, and the rising global demand for advanced therapy medicinal products. Furthermore, novel three-dimensional cell culture techniques and the growing need for them in biopharmaceutical development & vaccine production are expected to drive the market growth over the forecast period. The COVID-19 pandemic has presented researchers with the opportunity to investigate the novel contagious virus for the creation of therapeutic and diagnostic tools.

Numerous prominent pharmaceutical and biotechnology companies have been engaging in extensive R&D efforts to produce innovative vaccines, therapies, and testing kits. As a result, there has been a substantial increase in the need for cell culture tools in research applications. Furthermore, the pandemic has increased the demand for new cell-based models, organoids, and high-throughput screening platforms for research & drug discovery efforts. The urgency to combat the pandemic increased the demand for bioreactors and culture systems for applications in vaccine production and drug testing during the pandemic. In addition, several emerging and established players undertook various initiatives to capitalize on the increased demand for cell culture products due to the COVID-19 pandemic.

Gather more insights about the market drivers, restrains and growth of the Global cell culture market

Cell Culture Market Segments Highlights:

• The consumables segment accounted for the largest market share of 57.44% in 2022 and is expected to witness significant growth during the forecast period primarily due to recurring demand and purchase of consumables. The cell culture media segment accounted for the largest share of 42.76% of the consumables market in 2022.
• The biopharmaceutical production application segment dominated the market in 2022 with a revenue share of 32.15%. Biopharmaceutical applications of cell culture techniques are anticipated to expand due to the use of mammalian cell lines, such as the Chinese hamster ovary, in the production of biopharmaceuticals and the increasing demand for alternative medicines.
• North America held the largest market share of 35.90% in 2022. The large share is attributed to the region’s well-established pharmaceutical & biotech sectors and widely used, technologically advanced solutions in the U.S.
• The Asia Pacific region is projected to expand at the fastest CAGR of 13.79% over the forecast period due to the growing healthcare expenditure, rising awareness regarding cell and gene therapies, and a large potential for clinical research applications.

Browse through Grand View Research's Biotechnology Industry Research Reports.

• Whole Genome Sequencing Market: The global whole genome sequencing market size was estimated at USD 2.12 billion in 2024 and is expected to grow at a CAGR of 22.17% from 2025 to 2030.
• Whole Exome Sequencing Market: The global whole exome sequencing market size was estimated at USD 472.9 million in 2024 and is expected to grow at a CAGR of 18.44% from 2025 to 2030.

Cell Culture Market Segmentation

Grand view research has segmented the global cell culture market based on product, application, and region:

Cell Culture Product Outlook (Revenue, USD Million, 2018 - 2030)

• Consumables
  • Sera
    • Fetal Bovine Serum
    • Other
  • Reagents
    • Albumin
    • Others
  • Media
    • Serum-free Media
      • CHO Media
      • HEK 293 Media
      • BHK Medium
      • Vero Medium
      • Other Serum-free Media
    • Classical Media
    • Stem Cell Culture Media
    • Chemically Defined Media
    • Specialty Media
    • Other Cell Culture Media
  • Instruments
    • Culture Systems
    • Incubators
    • Centrifuges
    • Cryostorage Equipment
    • Biosafety Equipment
    • Pipetting Instruments

Cell Culture Application Outlook (Revenue, USD Million, 2018 - 2030)

• Biopharmaceutical Production
  • Monoclonal Antibodies
  • Vaccines Production
  • Other Therapeutic Proteins
• Drug Development
• Diagnostics
• Tissue Culture & Engineering
• Cell & Gene Therapy
• Toxicity Testing
• Other Applications

Cell Culture Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Order a free sample PDF of the Cell Culture Market Intelligence Study, published by Grand View Research.